- Potential benefitCreates a formal payment pathway that may speed Medicare reimbursement clarity for pediatric devices.
- ManufacturersMay incentivize manufacturers to develop or market pediatric-specific technologies by improving payment predictability.
- Potential benefitProvides an established timetable for requests, increasing regulatory predictability for stakeholders.
Access to Pediatric Technologies Act of 2025
Read twice and referred to the Committee on Finance.
Amends Social Security Act section 1848 to require the HHS Secretary to establish national relative value units (RVUs) under the Medicare physician fee schedule for certain 'qualifying pediatric technologies' when a manufacturer requests it. The Secretary must follow existing payment methodology, may use available pricing and claims data, and must act through the annual physician fee schedule rulemaking with specified timelines for requests.
Liberals emphasize safeguards against industry influence and evidence requirements
Relative to its intended legislative type, this bill is a targeted substantive change that is moderately well-constructed: it provides specific operative text to require the Secretary to establish RVUs for defined pediatric technologies via the existing physician fee schedule rulemaking process, with timelines and submission content specified.
Amends Social Security Act section 1848 to require the HHS Secretary to establish national relative value units (RVUs) under the Medicare physician fee schedule for certain 'qualifying pediatric technologies' when a manufacturer requests it.
The Secretary must follow existing payment methodology, may use available pricing and claims data, and must act through the annual physician fee schedule rulemaking with specified timelines for requests.
A qualifying pediatric technology is a Medicare-covered medical device with specific FDA authorization and a temporary Level I HCPCS code, predominantly used or designed for pediatric patients.
Technocratic, industry-favorable tweak with limited controversy and modest fiscal uncertainty makes enactment plausible, especially if bundled into broader Medicare legislation.
Relative to its intended legislative type, this bill is a targeted substantive change that is moderately well-constructed: it provides specific operative text to require the Secretary to establish RVUs for defined pediatric technologies via the existing physician fee schedule rulemaking process, with timelines and submission content specified.
Liberals emphasize safeguards against industry influence and evidence requirements
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenMay increase Medicare expenditures if new RVUs raise payment rates for provided pediatric technologies.
- ManufacturersImposes administrative workload on CMS to perform annual rulemaking and data evaluation for manufacturers' requests.
- Potential burdenCould enable payments before robust pediatric evidence or formal coverage determinations exist.
Why the argument around this bill splits.
Liberals emphasize safeguards against industry influence and evidence requirements
Likely cautiously supportive of measures that improve pediatric access, but concerned about industry influence and coverage certainty.
Views the bill as a narrow administrative fix that could help device payment setup, while wanting safeguards for transparency and equity.
Generally supportive as a targeted, procedural improvement to Medicare payment rules with modest scope.
Will look for fiscal transparency and clear implementation timelines to avoid unintended costs or regulatory delay.
Likely broadly favorable because it lowers administrative barriers and supports innovation without expanding coverage mandates.
Some concern remains about federal rate-setting and potential spending increases.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic, industry-favorable tweak with limited controversy and modest fiscal uncertainty makes enactment plausible, especially if bundled into broader Medicare legislation.
- No cost estimate or CBO score included
- Magnitude of potential Medicare spending change unknown
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals emphasize safeguards against industry influence and evidence requirements
Technocratic, industry-favorable tweak with limited controversy and modest fiscal uncertainty makes enactment plausible, especially if bund…
Relative to its intended legislative type, this bill is a targeted substantive change that is moderately well-constructed: it provides specific operative text to require the Secretary to establish RVUs for defined pedia…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.